Occurrence of protease-like catalytic activity in the polyclonal IgG in schizophrenia and bipolar disorder
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Occurrence of protease-like catalytic activity in the polyclonal IgG in schizophrenia and bipolar disorder ; volume:14 ; number:1 ; day:14 ; month:11 ; year:2024 ; pages:1-9 ; date:12.2024
Scientific reports ; 14, Heft 1 (14.11.2024), 1-9, 12.2024
- Urheber
-
Ramesh, Rajendran
Sundaresh, Aparna
Rajkumar, Ravi Philip
Negi, Vir Singh
Vijayalakshmi, M. A.
Kamalanathan, A. S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-75200-y
- URN
-
urn:nbn:de:101:1-2502040945466.678199024940
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ramesh, Rajendran
- Sundaresh, Aparna
- Rajkumar, Ravi Philip
- Negi, Vir Singh
- Vijayalakshmi, M. A.
- Kamalanathan, A. S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation
Preparation of polyclonal anti-Schistosoma mansoni cysteine protease antibodies for early diagnosis
Purification of polyclonal IgG specific for Camelid’s antibodies and their recombinant nanobodies
Membranoproliferative glomerulonephritis with deposition of monoclonal IgG evolved from polyclonal IgG: a case report with two consecutive renal biopsies
Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose
Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose
Role of anti-Giardia recombinant cyst wall protein IgG polyclonal antibodies in diagnosis and protection
Toxoplasma gondii IgG serointensity and cognitive function in bipolar disorder
I.G.G./Min.
Analysis of binding partners of polyclonal antithymocyte globulines
Characterization of a novel polyclonal anti-hypusine antibody
IGG: Band IX
Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation
Preparation of polyclonal anti-Schistosoma mansoni cysteine protease antibodies for early diagnosis
Purification of polyclonal IgG specific for Camelid’s antibodies and their recombinant nanobodies
Membranoproliferative glomerulonephritis with deposition of monoclonal IgG evolved from polyclonal IgG: a case report with two consecutive renal biopsies
Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose
Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose
Role of anti-Giardia recombinant cyst wall protein IgG polyclonal antibodies in diagnosis and protection
Toxoplasma gondii IgG serointensity and cognitive function in bipolar disorder
I.G.G./Min.
Analysis of binding partners of polyclonal antithymocyte globulines
Characterization of a novel polyclonal anti-hypusine antibody
IGG: Band IX
Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation
Preparation of polyclonal anti-Schistosoma mansoni cysteine protease antibodies for early diagnosis
Purification of polyclonal IgG specific for Camelid’s antibodies and their recombinant nanobodies
Membranoproliferative glomerulonephritis with deposition of monoclonal IgG evolved from polyclonal IgG: a case report with two consecutive renal biopsies
Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose
Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose
Role of anti-Giardia recombinant cyst wall protein IgG polyclonal antibodies in diagnosis and protection
Toxoplasma gondii IgG serointensity and cognitive function in bipolar disorder
I.G.G./Min.
Analysis of binding partners of polyclonal antithymocyte globulines
Characterization of a novel polyclonal anti-hypusine antibody